May 18, 2021 20:07 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
KK Shailaja won't be part of Pinarayi Vijayan cabinet in Kerala govt, set to become party whip | Has China launched biological warfare against India as second COVID-19 pandemic wave, expert questions | Cyclone Tauktae kills 3 in Gujarat, 6 in Maharashtra | Narada arrests: Madan Mitra, Sovan Chatterjee admitted to hospital after complaints of breathlessness | India records 4329 new COVID-19 deaths in past 24 hours
Covaxin neutralises double mutant strain: ICMR Covaxin
Image: Wikimedia Commons

Covaxin neutralises double mutant strain: ICMR

India Blooms News Service | @indiablooms | 21 Apr 2021, 05:22 pm

New Delhi: Covaxin, which is a Made-in-India COVID-19 vaccine, is able to neutralise  multiple variants of SARS-CoV-2 and effectively works against the double mutant strain as well, claimed the  Indian Council of Medical Research (ICMR) on Wednesday.

Bharat Biotech's Covaxin has received Emergency Use Authorizations (EUAs) for treating COVID-19 infected patients in India and in many other nations.

"ICMR study shows #COVAXIN neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well. @MoHFW_INDIA
#IndiaFightsCOVID19 #LargestVaccineDrive," ICMR tweeted.

The ICMR made the revelation at a time when India is witnessing a massive surge in COVID-19 infection cases.

India witnessed a massive spike in COVID-19 deaths as 2023 people died due to the virus in the past 24 hours, as per Ministry of Health website.

Continuing to witness the spike in daily count, India also recorded  2,95,041 new cases during the same period.

The total death toll due to the virus now stands at 1,82,553.

There are 2157538 active cases in the country at present.